Novo Nordisk A/S vs Sirius XM Holdings Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Sirius XM Holdings Inc trades at $30.24 (market cap $10.30B). The key difference: Novo Nordisk A/S is far larger — about 21.4× Sirius XM Holdings Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | SIRI | |
|---|---|---|
Market Cap | $220.53B | $10.30B |
Sector | Health | Media |
52-Week High | $71.70 | $31.22 |
52-Week Low | $35.29 | $19.92 |
Enterprise Value | $239.49B | $19.97B |
Dividend Yield | 3.63% | 3.53% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →